Abstract
Prostate cancer (PCa) is increasingly a global public health burden. The prostate specific antigen (PSA) is the major biomarker for diagnosing and managing PCa. Due to the importance of PSA as a biomarker and as a downstream product of the androgen receptor (AR), it was imperative to expose LNCaP cells to selective diet-derived phytochemicals and investigate the effect on PSA protein secretion. The phytochemicals: Curcumin, 3,3’-Diindolylmethane (DIM) and Epigallcatechin-3-gallate (EGCG) were utilised singly and in paired combinations as in vitro treatments. The ELISA technique was utilised to assess secreted PSA levels. Results obtained indicated that DIM posed inhibitory effects to PSA production and secretion. Uniquely, DIM lowered PSA levels significantly when compared to curcumin and EGCG. This finding corroborates with previous reports where DIM was observed to inhibit AR protein expression. It is suggestive that DIM targets the androgen receptor and its downstream pathway that produces PSA. In conclusion, DIM may hold overwhelming potential chemoprevention and management of PCa, and can be harnessed for enhanced clinical applications.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.